TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 5 | 6 | 8 | -6 | -37 | -94 | -95 | -36 |
S | %wins | 0 | 20 | 60 | 80 | 100 | 100 | 60 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/15 16:12 | 4/2/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Laba Rebecque J | CA | O | VP,Corpo | S.d | -190 | 17.30 | 33 | -11 | -79 | 3 | D | 60 | 79 | -9 | 9 | -34 | -28 | -18 | 3 | -3 | -86 | -93 | -95 | ||
3/9/15 20:42 | 3/6/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Laba Rebecque J | CA | O | VP,Corpo | S.d | -323 | 23.06 | 12 | -14 | -83 | 3 | D | 108 | 140 | 87 | 41 | 46 | 34 | 28 | 2 | 8 | -28 | -94 | -99 | ||
2/10/15 18:19 | 2/6/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Laba Rebecque J | CA | O | VP,Corpo | S.d | -225 | 16.08 | 3 | -14 | -83 | 3 | D | 108 | 44 | 35 | -18 | -11 | -12 | 0 | 5 | 4 | 65 | -85 | -94 | ||
1/8/15 18:42 | 1/7/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Laba Rebecque J | CA | O | VP,Corpo | S.d | -346 | 17.30 | 7 | -20 | -87 | 3 | D | 13 | 80 | 47 | -3 | -10 | -14 | 6 | 5 | -9 | -3 | -94 | |||
12/8/14 18:42 | 12/5/14 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Laba Rebecque J | CA | O | VP,Finan | S.d | -255 | 12.77 | 1 | -20 | -97 | 1 | D | 43 | 23 | 26 | 12 | 7 | 4 | 15 | 27 | 27 | 88 | -89 | -95 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |